Grape seed extract trial for prostate cancer halted early
NCT ID NCT02946996
Summary
This study tested whether a grape seed extract called OPC could reduce certain food-related substances (AGEs) in the blood of prostate cancer patients receiving hormone therapy. Researchers wanted to see if lowering AGE levels might help control cancer. The trial was terminated early after enrolling 41 men, and many planned measurements like quality of life surveys weren't completed due to staff changes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Conditions
Explore the condition pages connected to this study.